Pasithea Therapeutics Corp. Annual Nonoperating Income (Expense) in USD for 2021

Taxonomy & unit
us-gaap: USD
Description
The aggregate amount of income or expense from ancillary business-related activities (that is to say, excluding major activities considered part of the normal operations of the business).
Summary
Pasithea Therapeutics Corp. quarterly/annual Nonoperating Income (Expense) history and growth rate for 2021.
  • Pasithea Therapeutics Corp. Nonoperating Income (Expense) for the quarter ending September 30, 2024 was $4.77K, a 97.3% decline year-over-year.
Nonoperating Income (Expense), Annual (USD)
Period Value YoY Chg Change % Start Date End Date Report Filed
2021 $2.33M Jan 1, 2021 Dec 31, 2021 10-K 2022-03-30
* An asterisk sign (*) next to the value indicates that the value is likely invalid.